MedTrace Logo

Accuracy & Usability Study for Soberlink Cellular Device

NCT02794038 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2016-06-10

No results posted yet for this study

Summary

This study scope is to validate the accuracy and usability of the Soberlink Cellular Device in comparison to a predicate device, BACtrack S80 Pro.

Conditions

Interventions

DEVICE

Soberlink Cellular Device

BAC breath analyzer

DEVICE

BACtrack S80 Pro

BAC breath analyzer

Sponsors & Collaborators

  • Soberlink Healthcare LLC

    lead INDUSTRY

Principal Investigators

  • Shannon Hanrahan, PhD · Private Practice

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2016-06-30
Completion
2016-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02794038 on ClinicalTrials.gov